TrialJournal of inherited metabolic disease2014

Efficacy and safety of enzyme replacement therapy with BMN 110 (elosulfase alfa) for Morquio A syndrome (mucopolysaccharidosis IVA): a phase 3 randomised placebo-controlled study.

Christian J Hendriksz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.